
About Memphis Vision Care
Memphis Vision Care is a Healthcare company based in India founded in 2017. Manufacturing and supplying pharmaceutical products, including parenteral formulations, in India. The company has 25 employees. Its Indian entity Memphis Vision Care Private Limited reported revenue of βΉ27.83 Cr. Memphis Vision Care offers products and services including Ophthalmic Solutions and Cardiac Injections. Its focus areas include Pharmaceuticals, Drug Manufacturing, Parenteral Formulations and Medical Supplies.
Company details
Memphis Vision Care is identified as a pharmaceutical company that manufactures and supplies a variety of parenteral formulations in controlled environments, with facilities approved by international regulatory authorities. Quality is prioritized through adherence to cGMP standards that surpass WHO requirements, while innovation is applied to meet diverse therapeutic needs. Customer satisfaction is achieved by enhancing products, evaluating processes, and developing workforce skills, ensuring customized solutions for different markets are delivered effectively. This approach supports global health objectives.
- Headquarters India
- Employees 25
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Website memphisvisioncare.com
- Social Facebook
- Legal Name Memphis Vision Care Pvt. Ltd.
- Date of Incorporation 25 Mar, 2014
- Jurisdiction Chhatral, Gujarat, India
- Annual Revenue₹27.83 Cr
FY 2024 · +106% YoY
- Net Profit₹3.70 Cr
FY 2024 · 13% margin
- EBITDA₹6.26 Cr
FY 2024 · 23% margin
- Employee Count25
Associated legal entities of Memphis Vision Care
Memphis Vision Care operates through Memphis Vision Care Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Memphis Vision Care Private Limited CIN U52100GJ2014PTC079356 | Active | 25 Mar 2014 | Chhatral, Gujarat | ₹27.8 Cr | 25 | 4 | View details |
Products & Services of Memphis Vision Care
Memphis Vision Care offers a comprehensive portfolio of products and services, including Ophthalmic Solutions and Cardiac Injections.
Ophthalmic solutions are manufactured for eye care treatments, including products like hydroxypropyl methylcellulose and sodium hyaluronate.
Cardiac injections are produced for critical care, such as enoxaparin sodium and heparin sodium, and supplied for therapeutic use.
Board of directors of Memphis Vision Care Private Limited (Memphis Vision Care)
Memphis Vision Care Private Limited is the primary company behind Memphis Vision Care. The board of Memphis Vision Care Private Limited currently have 4 directors; the longest-serving is Parth Manilal Patel, appointed in 2014. 4 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Parth Manilal Patel DIN 06840777 | Director | 25 Mar 2014 | 12 yrs 7 mo | Memphis Vision Care Private Limited |
| Hitendra Rughunathbhai Barot DIN 08284747 | Director | 23 Nov 2018 | 7 yrs 11 mo | Memphis Vision Care Private Limited |
| Ekataben Vishnuprasad Patel DIN 08881169 | Director | 16 Sep 2020 | 6 yrs 2 mo | Memphis Vision Care Private Limited |
| Aakash Vishnuprasad Patel DIN 06840783 | Director | 06 May 2025 | 1 yr 6 mo | Memphis Vision Care Private Limited |
Financials of Memphis Vision Care
Figures of Memphis Vision Care Private Limited, the primary company behind Memphis Vision Care, for FY 2024. Revenue was ₹27.83 Cr (+106% year on year). Net profit was ₹3.70 Cr (13% margin). EBITDA was ₹6.26 Cr (23% margin). Revenue has grown at a compounded annual rate of +5% over three years and +62% over five years.
- ₹27.83 CrRevenue · FY 2024 · +106% YoY
- ₹3.70 CrNet profit · 13% margin
- ₹6.26 CrEBITDA · 23% margin
- ₹4.00 CrPaid-up capital
- 25Employees (provident fund records)
- +5%Revenue CAGR, 3 years
- +62%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Memphis Vision Care Private Limited are on its company page.
Detailed financial statements for Memphis Vision Care
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Memphis Vision Care
Memphis Vision Care was founded in 2017.
Memphis Vision Care is headquartered in India.
Memphis Vision Care has 25 employees.
The primary company behind Memphis Vision Care, Memphis Vision Care Private Limited, reported revenue of βΉ27.83 Cr for FY 2024, up 106% year on year.
Memphis Vision Care is identified as a pharmaceutical company that manufactures and supplies a variety of parenteral formulations in controlled environments, with facilities approved by international regulatory authorities. Quality is prioritized through adherence to cGMP standards that surpass WHO requirements, while innovation is applied to meet diverse therapeutic needs. Customer satisfaction is achieved by enhancing products, evaluating processes, and developing workforce skills, ensuring customized solutions for different markets are delivered effectively. This approach supports global health objectives.
Memphis Vision Care offers Ophthalmic Solutions and Cardiac Injections.
Memphis Vision Care operates through Memphis Vision Care Private Limited.
The legal entities of Memphis Vision Care currently have 4 directors, including Ekataben Vishnuprasad Patel, Aakash Vishnuprasad Patel, Parth Manilal Patel and others.